ARCL Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:35 pm

Quick Insight

ARCL Organics Ltd, based in Kolkata, currently trades at ₹253 with a market cap of ₹202 crore and a P/E ratio of 17.2. The company boasts a solid ROE of 16.8% and ROCE of 20.4%, indicating efficient capital utilization. With an OPM of 12.44%, ARCL has maintained a healthy bottom line, reflected in a net profit of ₹12 crore. The firm's strong reserves of ₹68 crore and manageable borrowings of ₹35 crore suggest a stable financial position. Additionally, the comfortable ICR of 6.23x indicates the company's ability to service debt obligations. Overall, ARCL Organics presents a promising investment opportunity given its robust financial performance and prudent capital structure.

Competitors of ARCL Organics Ltd

All Competitor Stocks of ARCL Organics Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:57 am

Below is a detailed analysis of the quarterly data for ARCL Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 72.24 Cr.. The value appears strong and on an upward trend. It has increased from 61.96 Cr. (Dec 2024) to 72.24 Cr., marking an increase of 10.28 Cr..
• For Expenses, as of Mar 2025, the value is 63.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.14 Cr. (Dec 2024) to 63.25 Cr., marking an increase of 5.11 Cr..
• For Operating Profit, as of Mar 2025, the value is 8.99 Cr.. The value appears strong and on an upward trend. It has increased from 3.82 Cr. (Dec 2024) to 8.99 Cr., marking an increase of 5.17 Cr..
• For OPM %, as of Mar 2025, the value is 12.44%. The value appears strong and on an upward trend. It has increased from 6.17% (Dec 2024) to 12.44%, marking an increase of 6.27%.
• For Other Income, as of Mar 2025, the value is 0.40 Cr.. The value appears to be declining and may need further review. It has decreased from 0.83 Cr. (Dec 2024) to 0.40 Cr., marking a decrease of 0.43 Cr..
• For Interest, as of Mar 2025, the value is 1.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.14 Cr. (Dec 2024) to 1.24 Cr., marking an increase of 0.10 Cr..
• For Depreciation, as of Mar 2025, the value is 1.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.29 Cr. (Dec 2024) to 1.42 Cr., marking an increase of 0.13 Cr..
• For Profit before tax, as of Mar 2025, the value is 6.73 Cr.. The value appears strong and on an upward trend. It has increased from 2.22 Cr. (Dec 2024) to 6.73 Cr., marking an increase of 4.51 Cr..
• For Tax %, as of Mar 2025, the value is 19.02%. The value appears to be improving (decreasing) as expected. It has decreased from 24.77% (Dec 2024) to 19.02%, marking a decrease of 5.75%.
• For Net Profit, as of Mar 2025, the value is 5.46 Cr.. The value appears strong and on an upward trend. It has increased from 1.67 Cr. (Dec 2024) to 5.46 Cr., marking an increase of 3.79 Cr..
• For EPS in Rs, as of Mar 2025, the value is 6.82. The value appears strong and on an upward trend. It has increased from 2.09 (Dec 2024) to 6.82, marking an increase of 4.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:26 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:51 pm

Below is a detailed analysis of the balance sheet data for ARCL Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 12.00 Cr..
• For Borrowings, as of Mar 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 29.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 50.00 Cr.. The value appears to be improving (decreasing). It has decreased from 55.00 Cr. (Mar 2024) to 50.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 161.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 148.00 Cr. (Mar 2024) to 161.00 Cr., marking an increase of 13.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 8.00 Cr..
• For Total Assets, as of Mar 2025, the value is 161.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2024) to 161.00 Cr., marking an increase of 13.00 Cr..

Notably, the Reserves (68.00 Cr.) exceed the Borrowings (35.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for ARCL Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
• For Cash EPS (Rs.), as of Mar 25, the value is 21.93. This value is within the healthy range. It has increased from 19.49 (Mar 24) to 21.93, marking an increase of 2.44.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 313.24. It has increased from 238.40 (Mar 24) to 313.24, marking an increase of 74.84.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 27.52 (Mar 24) to 32.70, marking an increase of 5.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is 26.19. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 26.19, marking an increase of 4.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.94. This value is within the healthy range. It has increased from 18.31 (Mar 24) to 20.94, marking an increase of 2.63.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
• For PBDIT Margin (%), as of Mar 25, the value is 10.43. This value is within the healthy range. It has decreased from 11.54 (Mar 24) to 10.43, marking a decrease of 1.11.
• For PBIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 9.29 (Mar 24) to 8.36, marking a decrease of 0.93.
• For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 6.68, marking a decrease of 1.00.
• For Net Profit Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 5. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 8. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.92. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 15.92, marking a decrease of 1.33.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.80. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 20.80, marking an increase of 0.86.
• For Return On Assets (%), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.30, marking an increase of 0.12.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.27 (Mar 24) to 0.20, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.44 (Mar 24) to 0.43, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has increased from 1.37 (Mar 24) to 1.54, marking an increase of 0.17.
• For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.48, marking an increase of 0.11.
• For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.27, marking an increase of 0.23.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.85. This value exceeds the healthy maximum of 8. It has increased from 7.98 (Mar 24) to 9.85, marking an increase of 1.87.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has decreased from 7.17 (Mar 24) to 6.23, marking a decrease of 0.94.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.94. This value is within the healthy range. It has decreased from 4.68 (Mar 24) to 3.94, marking a decrease of 0.74.
• For Enterprise Value (Cr.), as of Mar 25, the value is 198.81. It has increased from 48.46 (Mar 24) to 198.81, marking an increase of 150.35.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.79, marking an increase of 0.54.
• For EV / EBITDA (X), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from 2.20 (Mar 24) to 7.60, marking an increase of 5.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
• For Price / BV (X), as of Mar 25, the value is 2.37. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 2.37, marking an increase of 1.85.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.32 (Mar 24) to 0.06, marking a decrease of 0.26.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness